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Abstract. Social media and participatory health has emerged as a promising tool for 
health, including developing diagnostic tools and therapeutic interventions. In the 
realm of online health care delivery, artificial intelligence based counseling apps 
now enable patients to consult with a chatbot instead of an actual therapist. However, 
several ethical issues and implications became relevant with this shift to digital 
interventions and healthcare delivery. This panel will describe ethical issues related 
to recent developments in participatory health and social media including the digital 
exposome, importance of involving patients in the design of AI-based applications  
and ethics of social media research in healthcare. 
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1. Introduction 
In recent years, the digital transformation in healthcare has led to an integration of 
social media, wearables, mobile applications etc. into treatment programmes. Many 
health interventions delivered via mobile applications demonstrate similar efficiency as 
standard therapies. Clinical trials are run by means of mobile apps collecting sensor data 
or patient reported outcomes (e.g. Ally Science, http://allyscience.ch). Social media are 
used for patient recruitment in clinical trials [1]. Already in previous work, ethical issues 
related to participatory health and social media were collected and discussed [2]. 
However, the interest and awareness of ethics in this field increased in the last 5 years.  
Furthermore,  new technologies have become increasingly relevant e.g. conversational 
user interfaces, artificial intelligence, digital exposome and digital biomarkers raising 
additional ethical implications. Thus, this panel will explore ethical issues related to 
recent developments in participatory health and social media as well as open issues that 
have not been addressed previously such as transparency or trustworthiness of AI-based 
systems [3,4].  
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2. Brief outline of the presentations 
The panel comprises five short presentations followed by a discussion with the 
audience. As a collaboration between the IMIA Participatory Health and Social Media 
Working Group (IMIA PHSM WG) and the Exposome Informatics Working Group Data 
Mining and Big Data Analytics Working Group, this panel brings to bear the effort and 
resources of a diverse range of IMIA working group membership. 
Luis Fernandez Luque will address the importance of involving patients in the 
design of AI-based digital health solutions. He will elaborate how patients will be 
involved in a project on AI for cancer [5]. Digital health solutions are becoming 
increasingly personalized by the use of AI algorithms and data-driven personalization 
techniques. Many potential ethical challenges are emerging from this trend of pervasive 
data-driven personalization including privacy concerns, concerns of providing personal 
data and data quality.  
Guillermo Lopez Campos will address the opportunities that arise from digital 
biomarkers while highlighting the imperative necessity to address the ethical challenges 
associated with monitoring individual’s digital lives. He will explore the ethical 
implications that may arise from discovering incidental or secondary findings associated 
with the use of digital biomarkers and exposures. In recent times, there has been a 
movement to define digital biomarkers, as any type of digital measurement that can be 
used as a marker for a relevant biomedical process. Simultaneously, there is an increasing 
interest in studying the digital environment, how it can be monitored and how it can 
affect individuals in an area that we describe as the digital exposome [6].  
Elia Gabarron addresses ethical issues of social media for patient recruitment into 
research, for patient-healthcare provider communication and for health promotion. When 
using social media for patient recruitment into research, privacy and confidentiality 
issues should be a priority for the healthcare professional [2]. Healthcare providers 
willing to communicate on social media with patients must be aware of the risk of 
infringing on patient’ privacy and confidentiality, breaking standard procedures [7].  
Carol Bond reflects on ethics of online (qualitative) research. As well as being a 
place to recruit research participants, social media provides a rich source of information 
for researchers. Where this information collated, anonymized and used quantitatively 
relatively few ethical issues arise, although all researchers should ensure that appropriate 
ethical approval is sought. The issues when the information is analyzed qualitatively 
however are more challenging. Research has found that people who participate in online 
discussion boards do not object to the information they post being used in an aggregated 
form [8], but whilst there was agreement that they had put their information in the public 
domain the use of direct quotations was problematic for some people. Research methods 
need to change to reflect the rapidly developing world of social media. 
Finally, Kerstin Denecke outlines ethical aspects related to health chatbots. 
Interacting with a system in a human-like manner gained momentum with symptom 
checkers, bots who educate patients [9], or even apps that deliver cognitive behavior 
therapy. While technology targets developing chatbots that are as human-like as possible, 
this can become critical in healthcare. Users might forget that they are talking to 
machines, rely entirely on them and underestimate potential health risks. The underlying 
knowledge base has to be evidence-based to avoid patient harm due to incorrect or life 
threatening bad advice.  
3. Brief biographies of the panelists 
Dr. Kerstin Denecke is a professor of medical informatics at Bern University of Applied 
Sciences, Switzerland. She is a member of the German Society of Medical Computer 
Science, Biometry and Epidemiology (GMDS) and IMIA PHSM WG. Her research 
interests include medical language processing, information extraction, sentiment 
analysis, and text classification.  
Prof. Dr. Carol S Bond leads the Caring for Lifelong Health Research Centre at the 
University of Wolverhampton in the UK. She is the deputy editor of the BMJ Health & 
Care Informatics journal. Her research interests are around how people living with long 
term conditions use the internet and social media to support their own self management 
strategies.  
Luis Fernandez-Luque graduated from his PhD at the University of Tromso (Norway) 
and studied computer engineering at the University of Sevilla (Spain). He has been 
involved in digital health research for 15 years, working both in industry and academia 
in institutions. He is currently the Vice President for Working Groups and SIG at the 
International Medical Informatics Association. He is co-founder of Adhera Health 
(California, USA) and Salumedia Tecnologias (Seville, Spain). 
Dr. Elia Gabarron is senior researcher at the Norwegian Centre for E-health Research, 
University Hospital of North Norway. She is Co-Chair of the IMIA PHSM WG, and 
Associate Editor of the BMC Medical Informatics and Decision Making journal. Her 
research interests are centred around the use of social media for health, and especially its 
role in supporting and educating people to prevent and manage health conditions. 
Dr. Guillermo Lopez Campos is lecturer in Biomedical Informatics in the Centre for 
Experimental Medicine, Queen’s University Belfast. He is currently member of several 
IMIA working groups. His research interests cover different aspects related with the 
analysis and information management in translational bioinformatics and exposome 
informatics.  
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